Market Research Logo

Global Dry Eye Syndrome Market 2015-2019

Global Dry Eye Syndrome Market 2015-2019

About dry eye syndrome

Dry eye syndrome usually results in dryness of eyes due to deficient tear production or quick tear evaporation or deviation in tear uniformity. This syndrome is of two types: aqueous tear deficient dry eye and evaporative dry eye. In aqueous tear deficient dry eye, lacrimal glands do not produce enough tears, whereas meibomian gland dysfunction results in evaporative dry eye. Meibomian glands secrete lipids to slow tear evaporation and maintain tear stability. The symptoms include pain, redness, burning, and fatigue in the eye and decreased tolerance to continuous visual activity. Dry eye syndrome cannot be cured, but symptoms can be controlled. Teardrops and anti-inflammatory drugs are used in the treatment.

Technavio's analysts forecast the global dry eye syndrome market to grow at a CAGR of 4.75% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the global dry eye syndrome market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of teardrops and anti-inflammatory drugs used in the treatment of dry eye syndrome. Technavio's report, Global Dry Eye Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast as well as market segmentation. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA
Key vendors
  • Alcon
  • Allergan
  • Otsuka Holdings
  • Santen Pharmaceuticals
Other prominent vendors
  • Acadia Pharmaceuticals
  • Aciex
  • Allostera Pharma
  • arGentis
  • Auven Therapeutics (Celtic)
  • Bridge Pharma
  • Can-Fite
  • Cellzome
Key market driver
  • Growing prevalence of dry eye syndrome
  • For a full, detailed list, view our report
Key market challenge
  • Self-medication by patients
  • For a full, detailed list, view our report
Key market trend
  • Growing awareness about the syndrome
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Dry Eye Syndrome Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Dry Eye Syndrome Market: Alcon, Allergan, Otsuka Holdings and Santen Pharmaceuticals
Other Prominent Vendors in the market are: Acadia Pharmaceuticals, Aciex, Allostera Pharma, arGentis, Auven Therapeutics (Celtic), Bridge Pharma, Can-Fite and Cellzome
Commenting on the report, an analyst from Technavio’s team said: “There is no cure for dry eye; current treatment options offer only symptomatic relief. In addition, these therapies do not address the quality of the tears. Thus, there is a need for new drugs that control inflammation with improved efficacy or stimulate mucin and tear secretion. The current pipeline agents are aimed at controlling inflammation and restoring the normal amount of tears. Many of these pipeline candidates exhibit novel mechanisms of action. The approval of late-stage clinical molecules is expected to serve the needs of patients, thereby propelling market growth. These therapies might act alone or in combination with other therapies to provide more effective solutions for dry eye syndrome.”
According to the report, changes in lifestyle, especially the increased usage of electronic gadgets such as computers and TV has led to a significant rise in the number of cases of dry eye syndrome. Excessive eye contact with these devices results in strain on the eyes, diminishing visual alertness, and mucosal dryness or eye burning. Continuous and prolonged staring results in an incomplete eye blink, which in turn decreases the stability of the tear film, breaking it and causing ocular discomfort. Therefore, the increased adoption of lifestyle changes leading to dry eye syndrome will drive the market growth.
Further, the report states that reliance on self-medication is a major challenge in the market.

Companies Mentioned

Alcon, Allergan, Otsuka Holdings, Santen Pharmaceuticals, Acadia Pharmaceuticals, Aciex, Allostera Pharma, arGentis, Auven Therapeutics (Celtic), Bridge Pharma, Can-Fite, Cellzome

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Disease overview
    • Understanding dry eye syndrome
    • Types of dry eye syndrome
    • Risk factors for dry eye syndrome
    • Signs and symptoms
    • Causes of dry eye syndrome
    • Epidemiology
      • Table Regional prevalence of dry eye syndrome
    • Diagnosis
      • Table Diagnosis of dry eye syndrome
    • Disease management
      • Table Surgical options
      • Table Punctal plugs
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global dry eye syndrome market 2014-2019 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline analysis
    • Cyclokat
    • Diquas
    • EBI-005
    • MIM-D3
    • Lifitegrast
    • RGN-259
    • EBI-005
    • EGP-437
  • Market segmentation by sub-type of dry eye
    • Table Market segmentation by sub-type of dry eye
  • Market segmentation by drug type
    • Table Dry eye syndrome: pharmacologic therapy
    • Oral antibiotics
    • Eye drops
      • Table Artificial tears: Different generations
    • Eye inserts
    • Eye ointments
  • Geographical segmentation
    • Table Global dry eye syndrome market share 2014
  • Market drivers
    • Table Global dry eye syndrome: Key drivers
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Table Global dry eye syndrome: Key challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Table Global dry eye syndrome: Emerging trends
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2014
      • Table Global dry eye syndrome market share analysis 2014
      • Table Alcon: Business strategy
      • Table Alcon: Distribution of sales by category 2014
      • Table Alcon: Region-wise sales distribution 2014 ($ millions)
      • Table Alcon: Region-wise sales distribution 2013 ($ millions)
      • Table Systane: Global sales 2011-2014 ($ millions)
      • Table Allergan: Business strategy
      • Table Eye care pharmaceuticals: Global sales 2011-2014 ($ millions)
      • Table Restasis: Global sales 2011-2014 ($ millions)
      • Table Santen Pharmaceuticals: Business strategy
      • Table Hyalein: Global sales 2011-2014 ($ millions)
      • Table Diquas: Global sales 2011-2014 ($ millions)
      • Table Prescription ophthalmics : Global sales 2011-2014 ($ millions)
    • Other prominent vendors
  • Key vendor analysis
    • Alcon
      • Table Alcon: Business segmentation 2014
    • Allergan
      • Table Allergan: Business segmentation by revenue 2014
      • Table Allergan: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table Allergan: Geographical segmentation by revenue 2014
    • Otsuka Holdings
    • Santen Pharmaceuticals
      • Table Santen Pharmaceutical: Business/Product segmentation 2014 by revenue
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report